Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 4/16/16  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Kathleen M. Dungan

Wrong Dr. Kathleen M. Dungan?

Associate Professor, Associate Di...

Phone: (614) ***-****  HQ Phone
Email: k***@***.edu
The Ohio State University
1971 Neil Ave. 210 Baker Systems
Columbus , Ohio 43210
United States

Company Description: The Ohio State University at Marion serves as one of five regional campuses to the Columbus main campus. As a regional campus, Marion offers the same excellent...   more
Background

Employment History

Board Memberships and Affiliations

  • Division CME Committee
    Endocrine Society Clinical Endocrine Update

Education

  • OSU
  • MD
  • MD
    University of Rochester
  • MPH
51 Total References
Web References
Kathleen Dungan, MD, ...
www.RealCME.com [cached]
Kathleen Dungan, MD, MPH Associate Professor, Associate Division Director for Clinical Services Division of Endocrinology, Diabetes and Metabolism The Ohio State University
...
Kathleen Dungan, MD, MPH Dr. Dungan currently serves as the Associate director of Clinical Services for the OSU Division of Endocrinology, Diabetes & Metabolism and Director of the Endocrine clinical trials unit. She also serves on the division CME committee and on the planning committee for the Endocrine Society Clinical Endocrine Update. Dr. Dungan has published a variety of formats on clinical therapeutics of diabetes, type 1 and type 2. She has a clinical practice in ambulatory and inpatient settings.
...
Dr. Kathleen Dungan, has received the royalty from Up-to-Date®, and consulting fees from Eli Lilly and Company and GlaxoSmithKline. She has contracted research from Novo Nordisk Inc, GlaxoSmithKline, Sanofi-Aventis, Merck & Co., Inc., Astra-Zeneca, and has performed other CME services for Astra-Zeneca.
Diabetes Review
ediabetesreview.org [cached]
Kathleen Dungan, MD, MPH
Associate Professor, Associate Division Director for Clinical Services Division of Endocrinology, Diabetes and Metabolism The Ohio State University
...
Dr. Dungan currently serves as the Associate director of Clinical Services for the OSU Division of Endocrinology, Diabetes & Metabolism and Director of the Endocrine clinical trials unit. She also serves on the division CME committee and on the planning committee for the Endocrine Society Clinical Endocrine Update. Dr. Dungan has published a variety of formats on clinical therapeutics of diabetes, type 1 and type 2. She has a clinical practice in ambulatory and inpatient settings.
Planner Disclosure Kathleen Dungan, MD, MPH discloses that she is a principal investigator for AstraZeneca, GlaxoSmithKline, Sanofi-Aventis, Grifols, Merck & Co., Inc., and Regeneron Pharmaceuticals, Inc. She has served as a consultant for GlaxoSmithKline and Eli Lilly and Company, and has received honorarium from UpToDate®.
...
Kathleen Dungan, MD, MPH discloses that she is a principal investigator for AstraZeneca, GlaxoSmithKline, Sanofi-Aventis, Grifols, Merck & Co., Inc., and Regeneron Pharmaceuticals, Inc. She has served as a consultant for GlaxoSmithKline and Eli Lilly and Company, and has received honorarium from UpToDate®.
...
Kathleen Dungan, MD, MPH discloses that she is a principal investigator for AstraZeneca, GlaxoSmithKline, Sanofi-Aventis, Grifols, Merck & Co., Inc., and Regeneron Pharmaceuticals, Inc. She has served as a consultant for GlaxoSmithKline and Eli Lilly and Company, and has received honorarium from UpToDate®.
Kathleen Dungan, MD, ...
ediabetesreview.org [cached]
Kathleen Dungan, MD, MPH Associate Professor, Associate Division Director for Clinical Services Division of Endocrinology, Diabetes and Metabolism The Ohio State University
Our guest author is Kathleen ...
ediabetesreview.org [cached]
Our guest author is Kathleen Dungan, MD, MPH, Associate Professor and Associate Division Director for Clinical Services, in the Division of Endocrinology, Diabetes and Metabolism at The Ohio State University.
...
Dr. Dungan has indicated that there will be references to the unlabeled/unapproved use of lixisenatide.
MEET THE AUTHORS
Kathleen Dungan, MD, MPH Associate Professor, Associate Division Director of Clinical Services Division of Endocrinology, Diabetes and Metabolism The Ohio State University
...
Dr. Dungan has indicated that she has received grant and/or research funding from AstraZeneca, GlaxoSmithKline, Merck & Co., Inc., and Sanofi-Aventis. She has served as a consultant for GlaxoSmithKline and has been a paid member of committees, panels, or boards for Eli Lilly and Company. In addition, she has received honorarium from UpToDate®.
...
Kathleen Dungan, MD, MPH Associate Professor, Associate Division Director for Clinical Services Division of Endocrinology, Diabetes and Metabolism The Ohio State University
As an additional feature, this newsletter ...
ediabetesreview.org [cached]
As an additional feature, this newsletter issue contains brief interviews with some of the key researchers by eDiabetes Review Program Director, Dr. Kathleen Dungan from The Ohio State University.
...
Kathleen Dungan, MD, MPH Associate Professor, Associate Division Director for Clinical Services Division of Endocrinology, Diabetes and Metabolism The Ohio State University
...
Kathleen Dungan, MD, MPH has indicated that she has received grant/research funding from AstraZeneca, GlaxoSmithKline, Merck, and Sanofi Aventis. She has served as a consultant for GlaxoSmithKline and has been a paid member of committees, panels, or boards for Eli Lilly and Company, and has received honorarium from UpToDate®.
...
Kathleen Dungan, MD, MPH Associate Professor, Associate Division Director for Clinical Services Division of Endocrinology, Diabetes and Metabolism The Ohio State University
...
Click here to hear eDiabetes Review Program Director Dr. Kathleen Dungan discuss "FLAT-SUGAR" with study author Dr. Andrew J. Ahmann
...
Commentary from Program Director Dr. Kathleen Dungan:
...
Commentary from Program Director Dr. Kathleen Dungan:
...
Click here to hear eDiabetes Review Program Director Dr. Kathleen Dungan discuss "Diet and Remission of Impaired Glucose Tolerance" with study author Dr. Frankie B. Stentz
...
Commentary from Program Director Dr. Kathleen Dungan:
Other People with the name "Dungan":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.